Uppsala Monitoring Centre,
The antiviral drug Remdesivir was the first to be conditionally approved to treat COVID-19. But with limited safety information…
Remdesivir in the COVID-19 Pandemic: An Analysis of Spontaneous Reports in VigiBase During 2020
Overview of attention for article published in Drug Safety, August 2021
Altmetric Badge
About this Attention Score
-
In the top 25% of all research outputs scored by Altmetric
-
High Attention Score compared to outputs of the same age (92nd percentile)
-
High Attention Score compared to outputs of the same age and source (80th percentile)
Readers on
- mendeley
- 72 Mendeley